Maxim V. Jasko

Maxim V. Jasko

Auto-generated profile, based on publicly available information

Maxim V. Jasko

Engelhardt Institute of Molecular Biology Russian Academy of Sciences, Moscow, Russia

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 1997 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
IFIvan I. Fedorov
Ivan I. Fedorov
EKEma M. Kazmina
Ema M. Kazmina
GGGalina V. Gurskaya
Galina V. Gurskaya
MJMaxim V. Jasko
Maxim V. Jasko
VZValery E. Zavodnic
Valery E. Zavodnic
GGGilles Gosselin
Gilles Gosselin

4 February 2022 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
LALiudmila Alexandrova
Liudmila Alexandrova
OSOleg V. Shevchenko
Oleg V. Shevchenko
MJMaxim V. Jasko
Maxim V. Jasko
PSPavel Solyev
Pavel Solyev
IKInna Karpenko
Inna Karpenko
Alexander ZhgunAlexander Zhgun
Alexander Zhgun
A set of 3′-modified N4-alkyl-5-methyl-2′-deoxycytidines has been synthesized and evaluated for biological activity. The replacement of the 3′-hydroxyl group with amino, aminoethyl and dialkylamino groups significantly enhances antifungal activity.

Verified
Journal Article
Open access
PDF file
LALiudmila Alexandrova
Liudmila Alexandrova
IOIvan A. Oskolsky
Ivan A. Oskolsky
DMDmitry A. Makarov
Dmitry A. Makarov
MJMaxim V. Jasko
Maxim V. Jasko
IKInna L. Karpenko
Inna L. Karpenko
Alexander ZhgunAlexander Zhgun
Alexander Zhgun
The rapid increase in the antibiotic resistance of microorganisms, capable of causing diseases in humans as destroying cultural heritage sites, is a great challenge for modern science. In this regard, it is necessary to develop fundamentally novel and highly active compounds. In this study, a series of N4-alkylcytidines, including 5- and 6-methylcytidine derivatives, with extended alkyl substituents, were obtained in order to develop a new generation of antibacterial and antifungal biocides based on nucleoside derivatives. It has been shown that N4-alkyl 5- or 6-methylcytidines effectively inhibit the growth of molds, isolated from the paintings in the halls of the Ancient Russian Paintings of the State Tretyakov Gallery, Russia, Moscow. The novel compounds showed activity similar to antiseptics commonly used to protect works of art, such as benzalkonium chloride, to which a number of microorganisms have acquired resistance. It was also shown that the activity of N4-alkylcytidines is comparable to that of some antibiotics used in medicine to fight Gram-positive bacteria, including resistant strains of Staphylococcus aureus and Mycobacterium smegmatis. N4-dodecyl-5- and 6-methylcytidines turned out to be the best. This compound seems promising for expanding the palette of antiseptics used in painting, since quite often the destruction of painting materials is caused by joint fungi and bacteria infection.

1 January 2021 in Molecular Biology
Verified
Journal Article
Closed access
PDF file
SNS. D. Negrya
S. D. Negrya
MJM. V. Jasko
M. V. Jasko
DMDmitry A. Makarov
Dmitry A. Makarov
PSPavel Solyev
Pavel Solyev
IKInna Karpenko
Inna Karpenko
LALiudmila Alexandrova
Liudmila Alexandrova
Resistance developed to the majority of drugs used to treat infectious diseases warrants the design of new compounds effective against drug-resistant strains of pathogens. Recently, several groups of modified nucleosides have been synthesized and showed significant antibacterial activity in vitro, but their further studies were difficult to undertake because of their low solubility in aqueous solutions. Nevertheless, new compounds, well soluble in water-organic solutions, were synthesized and found to be more effective in inhibiting the growth of Gram-positive bacteria and mycobacteria. The water-soluble forms of modified nucleosides under study were assumed to be their depot forms. To check the assumption, the compounds were tested for hydrolysis in various media and their molecular docking was performed into the active center of the putative target, Mycobacterium tuberculosis flavin-dependent thymidylate synthase ThyX. Computer modelling showed that the water-soluble analogs do not act as ThyX inhibitors, supporting the assumption of their depot nature. The compounds were resistant to chemical hydrolysis but were hydrolyzed when incubated with porcine liver carboxylesterase, human serum, or Staphylococcus aureus 209P. The results demonstrate that the compounds are most likely depot forms of modified nucleosides.

4 October 2023 in ChemMedChem
Verified
Journal Article
Closed access
DMDmitry A. Makarov
Dmitry A. Makarov
SNSergey D. Negrya
Sergey D. Negrya
MJMaxim V. Jasko
Maxim V. Jasko
IKInna Karpenko
Inna Karpenko
PSPavel Solyev
Pavel Solyev
LALiudmila Alexandrova
Liudmila Alexandrova

13 March 2007 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
LALudmila A. Alexandrova
Ludmila A. Alexandrova
MJMaxim V. Jasko
Maxim V. Jasko
EBElena E. Belobritskaya
Elena E. Belobritskaya
ACAlexander Vasilyevich Chudinov
Alexander Vasilyevich Chudinov
OMOlga Mityaeva
Olga Mityaeva
MKMarina K. Kukhanova
Marina K. Kukhanova